Showing 9771-9780 of 18563 results for "".
- Innovations Reshaping Orthopedic Surgery: From Femoral Neck Fractures to Advanced Spinal Navigationhttps://reachmd.com/news/innovations-reshaping-orthopedic-surgery-from-femoral-neck-fractures-to-advanced-spinal-navigation/2474961/Innovations in orthopedic surgery are redefining treatment paradigms, especially in managing femoral neck fractures and navigating complex spinal procedures. Advancements in technology have led to significant improvements in surgical precisio
- Managing Motor Fluctuations in Parkinson's Disease: Emerging Therapies and Research Insightshttps://reachmd.com/news/managing-motor-fluctuations-in-parkinsons-disease-emerging-therapies-and-research-insights/2474988/Managing motor fluctuations in Parkinson's disease remains a central clinical challenge, as neurologists grapple with the limitations of traditional oral regimens and explore continuous subcutaneous infusion therapies like
- Impact of ESUR Guidelines on MRI Imaging for Endometriosishttps://reachmd.com/news/impact-of-esur-guidelines-on-mri-imaging-for-endometriosis/2474958/Variability in MRI imaging for endometriosis contributes to inconsistent diagnoses and hinders patient outcomes, driving a shift toward the ESUR guidelines to standardize protocols and reporting. The complexities of diagnosing endometr
- Patent Issued for Coya’s IL-2 Technologyhttps://reachmd.com/news/patent-issued-for-coyas-il-2-technology/2474992/Coya Therapeutics has received a new U.S. patent for proprietary methods of producing a highly stable liquid formulation (aldesleukin) of recombinant human interleukin-2 (rhIL-2), according to a press release from the manufacturer.
- Evolving Strategies to Prevent Cancer in Inflammatory Bowel Disease: Integrating Therapeutics and Surgeryhttps://reachmd.com/news/evolving-strategies-to-prevent-cancer-in-inflammatory-bowel-disease-integrating-therapeutics-and-surgery/2474985/In inflammatory bowel disease, persistent mucosal injury in ulcerative colitis and Crohn's disease poses a significant cancer risk, yet many clinicians grapple with controlling chronic low-grade inflammation before dysplasia emerges. C
- Advancing Bladder Cancer Treatment: FDA's Impact on Perioperative Durvalumab and Emerging UGN-102https://reachmd.com/news/advancing-bladder-cancer-treatment-fdas-impact-on-perioperative-durvalumab-and-emerging-ugn-102/2474986/Explore the latest advancements in bladder cancer treatment with an in-depth look at the FDA's approval of perioperative durvalumab for muscle-invasive bladder cancer (MIBC) and the anticipated decision on UGN-102 for non-muscle-invasive blad
- Exploring Psychedelic Medicine for IBS Reliefhttps://reachmd.com/news/exploring-psychedelic-medicine-for-ibs-relief/2475007/Despite advances in gastroenterology, a significant proportion of patients with irritable bowel syndrome report inadequate relief, leading to increased interest in innovative treatment approaches. Traditional IBS therapies—ranging from
- Shifting Paradigms: Molecular Targets in IBD for Cancer Preventionhttps://reachmd.com/news/shifting-paradigms-molecular-targets-in-ibd-for-cancer-prevention/2474982/Gastroenterologists face a critical blind spot: young adults with inflammatory bowel disease (aged 20 to 39) are at a growing risk of bowel cancer when chronic inflammation
- Evolving Approaches in Cardiovascular Risk: The Impact of sdLDL-C/LDL-C and Nanoparticle Therapieshttps://reachmd.com/news/evolving-approaches-in-cardiovascular-risk-the-impact-of-sdldl-cldl-c-and-nanoparticle-therapies/2474979/Atherosclerotic cardiovascular disease persists despite widespread LDL-C–lowering therapy, underscoring the need for advanced metrics like the small dense LDL cholesterol (sdLDL-C)/LDL-C ratio and targeted immunosuppressive nanoparticles to r
- Evolving Strategies: The Role of Combined COVID-19 and Influenza Vaccinations in 2025https://reachmd.com/news/evolving-strategies-the-role-of-combined-covid-19-and-influenza-vaccinations-in-2025/2474964/As flu season 2025 approaches, co-administration of COVID-19 and influenza shots has emerged as an urgent tactic to enhance public health outcomes and alleviate healthcare pressures. Clinicians brace for a surge of respiratory illnesse